SCHEMBL16629029

SCHEMBL16629029

Nc1ncc(-c2ccccc2)nc1I

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATR Q13535 5/20 0.51
PRKDC P78527 1/20 0.49
TLR9 Q9NR96 1/20 0.49
ADORA2A P29274 2/20 0.44
AURKA O14965 1/20 0.44
HSP90AA1 P07900 1/20 0.44
PRKACA P17612 1/20 0.44
ADORA1 P30542 1/20 0.44
NEK2 P51955 1/20 0.43
MAPKAPK2 P49137 1/20 0.43
NPC1 O15118 1/20 0.43
PDGFRB P09619 1/20 0.43
KDR P35968 1/20 0.43
FLT3 P36888 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NOS1 P29475 1/20 0.43
ASIC3 Q9UHC3 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29519952 0.82 ATR (0.56) ATRPRKDCTLR9ADORA2AAURKA
SCHEMBL12489014 0.82 ATR (0.56) ATRPRKDCTLR9ADORA2AAURKA
SCHEMBL23064157 0.81 PIK3CG (0.54) ATRPRKDCMAPK1
SCHEMBL24731316 0.80 HSD17B1 (0.59) ATRPRKDCADORA1NPC1FLT3
SCHEMBL32688927 0.78 ATR (0.66) ATRPRKDCTLR9
SCHEMBL6701248 0.78 ATR (0.66) ATRPRKDCTLR9
SCHEMBL934804 0.77 ATR (0.51) ATRPRKDCTLR9ADORA2AAURKA
SCHEMBL31638393 0.77 ATR (0.51) ATRPRKDCTLR9ADORA2AAURKA
SCHEMBL2681285 0.77 SMN1; SMN2 (0.51) ATRPRKDCTLR9ADORA2AAURKA
SCHEMBL24731315 0.76 ATR (0.56) ATRPRKDCADORA2AADORA1NEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4066834-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF PI3K-GAMMA MEDIATED DISORDERS Infinity Pharmaceuticals, Inc. (US) 2022-10-05 EP disclosed
WO-2015051241-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2015-04-09 WO disclosed